HMG CoA reductase inhibitors
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ROSUVASTATIN CALCIUM: products 41 to 60 of 80.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Mint-Rosuvastatin 10mg TabDIN 02397803 | General benefit | $0.1354per source unit | Requirements & sourcesBuild cost plan |
| Mint-Rosuvastatin 20mg TabDIN 02397811 | General benefit | $0.1692per source unit | Requirements & sourcesBuild cost plan |
| Mint-Rosuvastatin 40mg TabDIN 02397838 | General benefit | $0.1990per source unit | Requirements & sourcesBuild cost plan |
| Mint-Rosuvastatin 5mg TabDIN 02397781 | General benefit | $0.1284per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin 10mg TabDIN 02477491 | General benefit | $0.1354per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin 20mg TabDIN 02477505 | General benefit | $0.1692per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin 40mg TabDIN 02477513 | General benefit | $0.1990per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin 5mg TabDIN 02477483 | General benefit | $0.1284per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin Tablets 10mg TabDIN 02536609 | General benefit | $0.1354per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin Tablets 20mg TabDIN 02536625 | General benefit | $0.1692per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin Tablets 40mg TabDIN 02536633 | General benefit | $0.1990per source unit | Requirements & sourcesBuild cost plan |
| NRA-Rosuvastatin Tablets 5mg TabDIN 02536595 | General benefit | $0.1284per source unit | Requirements & sourcesBuild cost plan |
| PMS-Rosuvastatin 10mg TabDIN 02378531 | General benefit | $0.1354per source unit | Requirements & sourcesBuild cost plan |
| PMS-Rosuvastatin 20mg TabDIN 02378558 | General benefit | $0.1692per source unit | Requirements & sourcesBuild cost plan |
| PMS-Rosuvastatin 40mg TabDIN 02378566 | General benefit | $0.1990per source unit | Requirements & sourcesBuild cost plan |
| PMS-Rosuvastatin 5mg TabDIN 02378523 | General benefit | $0.1284per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Rosuvastatin 10mg TabDIN 02505584 | General benefit | $0.1354per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Rosuvastatin 20mg TabDIN 02505592 | General benefit | $0.1692per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Rosuvastatin 40mg TabDIN 02505606 | General benefit | $0.1990per source unit | Requirements & sourcesBuild cost plan |
| PRZ-Rosuvastatin 5mg TabDIN 02505576 | General benefit | $0.1284per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
Products assigned to this ATC category in the held Health Canada records. Combinations assigned to other categories are not included; search their ingredient or product name separately.
C10AA HMG CoA reductase inhibitors. Health Canada DPD extract 2026-09-02.
WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index, 2026-01-20
C10AA HMG CoA reductase inhibitors